SCHEMBL3408312

SCHEMBL3408312

O=C(NCc1ccccc1)c1c(=O)[nH]n2c(=O)c3c([nH]c12)CCCC3

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.49
MAPT P10636 4/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TSHR P16473 1/20 0.47
PKM P14618 1/20 0.45
KMT2A Q03164 7/20 0.44
LMNA P02545 4/20 0.44
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
HPGD P15428 7/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3410031 0.84 MAPT (0.52) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3407592 0.82 MAPT (0.50) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3408224 0.78 MAPT (0.50) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL13597924 0.78 ALDH1A1 (0.71) TDP1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL3411768 0.76 MAPT (0.46) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3409992 0.76 POLB (0.50) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3405825 0.75 MAPT (0.55) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3410083 0.74 LMNA (0.48) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3411499 0.74 MAPT (0.47) TDP1MAPTL3MBTL1ALDH1A1KDM4E
SCHEMBL3411765 0.74 MAPT (0.43) TDP1MAPTL3MBTL1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP claimed
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed